Label: TOBAKIENT- ascorbic acid, cholecalciferol, riboflavin, pyridoxine hcl, folic acid, l-glutathione, astaxanthin capsule

  • Category: DIETARY SUPPLEMENT

Drug Label Information

Updated February 20, 2019

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

  • PRINCIPAL DISPLAY PANEL

    Tobakient

    Supplement Facts

  • STATEMENT OF IDENTITY

    Tobakient™ Capsules Dietary Supplement

  • Health Claim

    Dispensed by Prescription†

    Tobakient™ is an orally administered prescription vitamin formulation for the clinical dietary management of suboptimal nutritional status in patients experiencing physiologically stressful conditions such as use of tobacco products, or to maintain levels when dietary intake of vitamins is inadequate or excretion or loss is excessive. ††

    †This product is a prescription- folic acid with or without other dietary ingredients that – due to increased folic acid levels increased risk associated with masking of B12
    deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (61 FR 8760). The most appropriate way to ensure pedigree
    reporting consistent with these regulatory guidelines and safety monitoring is to dispense this product only by prescription (Rx). This is not an Orange Book product.
    This product may be administered only under a physician’s supervision and all prescriptions using this product shall be pursuant to state statutes as applicable. The
    ingredients, indication or claims of this product are not to be construed to be drug claims.

    1. Federal Register Notice of August 2, 1973 (38 FR 20750)

    2. Federal Register Notice of October 17, 1980 (45 FR 69043, 69044)

    3. Federal Register Notice of March 5, 1996 (61 FR 8760)

    †† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

  • WARNINGS

    This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

  • PRECAUTIONS

    Tobakient™ capsules should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.

  • DOSAGE & ADMINISTRATION

    Usual adult dose is one (1) capsule once or twice daily or as prescribed by a licensed medical practitioner.

    Tobakient™ capsules are supplied as (blue and white, oblong-shaped) capsules in a child-resistant bottle of 30-count ("71905-0100-30"**).

    **Levins Pharmaceuticals does not represent these product codes to be National Drug Codes (NDC). Product codes are formatted according to standard industry practice, to meet the formatting requirement by pedigree reporting and supply-chain control including pharmacies.

  • SAFE HANDLING WARNING

    Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.]

    KEEP OUT OF REACH OF CHILDREN

    Tamper evident: Do not use if seal is broken or missing

    To report adverse events or to obtain product information, contact 228-392-0043.

  • INGREDIENTS AND APPEARANCE
    TOBAKIENT 
    ascorbic acid, cholecalciferol, riboflavin, pyridoxine hcl, folic acid, l-glutathione, astaxanthin capsule
    Product Information
    Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:71905-100
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN1.7 mg
    ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID200 mg
    PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE2 mg
    GLUTATHIONE (UNII: GAN16C9B8O) (GLUTATHIONE - UNII:GAN16C9B8O) GLUTATHIONE250 mg
    CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL20 ug
    ASTAXANTHIN (UNII: 8XPW32PR7I) (ASTAXANTHIN - UNII:8XPW32PR7I) ASTAXANTHIN4 mg
    FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1667 ug
    Inactive Ingredients
    Ingredient NameStrength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    GELATIN (UNII: 2G86QN327L)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NHRIC:71905-100-3030 in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    dietary supplement03/04/2019
    Supplement Facts
    Serving Size : Serving per Container :
    Amount Per Serving% Daily Value
    size (solid drugs)21 mm
    scoring1
    color
    color
    shape
    Labeler - Levins Pharmaceuticals, LLC (080839485)
    Registrant - Levins Pharmaceuticals, LLC (080839485)
    Establishment
    NameAddressID/FEIBusiness Operations
    FORMULIFE, INC.024442806